Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M10,086Revenue $M4,119Net Margin (%)14.1Altman Z-Score2.3
Enterprise Value $M9,204EPS $0.9Operating Margin %24.9Piotroski F-Score5
P/E(ttm)23.1Beneish M-Score-3.9Pre-tax Margin (%)18.0Higher ROA y-yN
Price/Book3.910-y EBITDA Growth Rate %--Quick Ratio1.5Cash flow > EarningsY
Price/Sales3.35-y EBITDA Growth Rate %26.6Current Ratio2.9Lower Leverage y-yN
Price/Free Cash Flow69.2y-y EBITDA Growth Rate %15.0ROA % (ttm)6.0Higher Current Ratio y-yY
Dividend Yield %2.4PEG0.9ROE % (ttm)18.3Less Shares Outstanding y-yY
Payout Ratio %32.0Shares Outstanding M688ROIC % (ttm)15.5Gross Margin Increase y-yN

Gurus Latest Trades with GRFS

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
GRFSMario Gabelli 2015-12-31 Add0.01%$15.84 - $17.79
($16.9)
$ 14.67-13%Add 119.08%57,400
GRFSJohn Paulson 2015-09-30 Reduce-0.01%$29.49 - $33.56
($31.74)
$ 14.67-54%Reduce -0.52%17,729,140
GRFSRon Baron 2015-09-30 Add$29.49 - $33.56
($31.74)
$ 14.67-54%Add 6.06%35,000
GRFSMario Gabelli 2015-09-30 Reduce$29.49 - $33.56
($31.74)
$ 14.67-54%Reduce -13.25%26,200
GRFSJohn Paulson 2015-06-30 Add$30.4 - $34.85
($32.43)
$ 14.67-55%Add 0.11%17,821,040
GRFSRon Baron 2015-06-30 Reduce$30.4 - $34.85
($32.43)
$ 14.67-55%Reduce -12.70%33,000
GRFSMario Gabelli 2015-06-30 Add$30.4 - $34.85
($32.43)
$ 14.67-55%Add 8.37%30,200
GRFSMario Gabelli 2015-03-31 Add$31.37 - $35.55
($33.48)
$ 14.67-56%Add 16.27%27,868
GRFSJohn Paulson 2015-03-31 Add$31.37 - $35.55
($33.48)
$ 14.67-56%Add 0.05%17,801,740
GRFSJohn Paulson 2014-12-31 Reduce-0.27%$29.77 - $37.24
($34.46)
$ 14.67-57%Reduce -9.25%17,792,140
GRFSRon Baron 2014-03-31 Add$34.91 - $42.83
($39.7)
$ 14.67-63%Add 65.77%44,757
GRFSSteve Mandel 2013-12-31 Sold Out -0.6%$28.78 - $36.23
($32.02)
$ 14.67-54%Sold Out0
GRFSMario Gabelli 2013-12-31 Add$28.78 - $36.23
($32.02)
$ 14.67-54%Add 25.07%29,977
GRFSRon Baron 2013-06-30 Reduce$25.84 - $31.23
($28.1)
$ 14.67-48%Reduce -26.73%27,000
GRFSSteve Mandel 2012-12-31 Add0.67%$22.46 - $25.27
($23.36)
$ 14.67-37%Add 1919.04%4,437,327
GRFSJohn Paulson 2012-12-31 Add0.6%$22.46 - $25.27
($23.36)
$ 14.67-37%Add 23.16%20,179,935
GRFSRon Baron 2012-12-31 Reduce$22.46 - $25.27
($23.36)
$ 14.67-37%Reduce -22.30%38,850
GRFSJohn Paulson 2012-09-30 Add0.98%$18.44 - $21.83
($19.89)
$ 14.67-26%Add 46.23%17,205,088
GRFSSteve Mandel 2012-09-30 Buy 0.03%$18.44 - $21.83
($19.89)
$ 14.67-26%New holding230,763
GRFSMario Gabelli 2012-09-30 Buy $18.44 - $21.83
($19.89)
$ 14.67-26%New holding29,211
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

GRFS is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


GRFS: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Quarterly/Annual Reports about GRFS:

    News about GRFS:

    Articles On GuruFocus.com
    Gold-Focused Guru John Paulson Reports First Quarter Holdings May 22 2014 
    Is Grifols Being Overlooked? Mar 19 2014 
    John Paulson's Top Five Holdings Nov 20 2013 
    John Paulson's Top Five Holdings Sep 12 2013 
    Baron Funds Comments on Grifols SA Aug 30 2012 
    Friday Value Overview Aug 19 2011 

    More From Other Websites
    Grifols, S.A. upgraded by Berenberg Feb 09 2016
    Technical Recap on Biotechnology Equities -- Biogen, Medivation, Grifols, and Agios Pharma Feb 05 2016
    Grifols invests in the project led by AlbaJuna Therapeutics, a spin-off from IrsiCaixa, to fund the... Jan 26 2016
    Grifols invests in the project led by AlbaJuna Therapeutics, a spin-off from IrsiCaixa, to fund the... Jan 26 2016
    GRIFOLS SA Financials Jan 16 2016
    How it All Plays Out - Analyst Reports on KapStone Paper and Packaging, Heartland Express, Grifols... Jan 13 2016
    Grifols Obtains Exclusive Rights to Market and Distribute MassBiologics' Tetanus and Diphtheria... Jan 08 2016
    8 Biotech Stocks That Should Be in Your Portfolio Right Now Dec 23 2015
    Grifols makes public its succession plan: the envisaged generational handover reiterates the... Dec 14 2015
    Grifols makes public its succession plan: the envisaged generational handover reiterates the... Dec 14 2015
    Look for These Stock to Break Above Resistance Dec 07 2015
    Is Grifols SA, Barcelona (GRFS) A Good Stock To Buy? Dec 02 2015
    Here is What Hedge Funds Think About Textron Inc. (TXT) Dec 01 2015
    Inauguration of the Grifols Chair for the Study of Cirrhosis Nov 30 2015
    Should You Buy Goldcorp Inc. (USA) (GG)? Nov 27 2015
    Is MGM Resorts International (MGM) A Good Stock To Buy? Nov 23 2015
    Grifols (GRFS): Moving Average Crossover Alert Nov 06 2015
    The intermediate results from the Grifols AMBAR study support its continuation Nov 06 2015
    The intermediate results from the Grifols AMBAR study support its continuation Download (31.1 Kb) Nov 06 2015
    Grifols’ net profit rises by 18.5% to exceed Euros 400 million, and revenue rises by 17.8% to... Nov 04 2015

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK